Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.

Hébert G, Netzer F, Ferrua M, et al. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool. Eur J Cancer. 2015;51(3):427-35. doi:10.1016/j.ejca.2014.12.002.

Save
Print
February 25, 2015
Hébert G, Netzer F, Ferrua M, et al. Eur J Cancer. 2015;51(3):427-35.
View more articles from the same authors.

This study describes the development and validation of an oncology trigger tool, modeled after the Institute for Healthcare Improvement's Global Trigger Tool, to capture adverse drug events during cancer care. The final tool included 22 triggers and achieved high interrater reproducibility, but had only a modest 20% positive predictive value.

Save
Print
Cite
Citation

Hébert G, Netzer F, Ferrua M, et al. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool. Eur J Cancer. 2015;51(3):427-35. doi:10.1016/j.ejca.2014.12.002.

Related Resources From the Same Author(s)
Related Resources